Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Long-term potentiation | R-HSA-9620244 | map04720 | cinchocaine | 3025 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | amiloride | 16231 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | amiloride | 16231 | drug-path |
| Primary immunodeficiency | R-HSA-5601905 | map05340 | amiloride | 16231 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | amiloride | 16231 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | amiloride | 16231 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | amiloride | 16231 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | amiloride | 16231 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | amiloride | 16231 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | amiloride | 16231 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | amiloride | 16231 | drug-path |
| Asthma | R-HSA-444620 | map05310 | amiloride | 16231 | drug-path |
| Basal transcription factors | R-HSA-3232118 | map03022 | amiloride | 16231 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | amiloride | 16231 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | amiloride | 16231 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | amiloride | 16231 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | amiloride | 16231 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | amiloride | 16231 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | amiloride | 16231 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | levodopa | 6047 | drug-path |